Company intelligence / Profile preview

HESTA

Melbourne, Victoria, Australia

Ownership: Private
Employees: ~872
Development stage: Other

Overview

HESTA is not a biotech or pharma developer; it is an Australian industry superannuation fund for health and community services workers that acts as an institutional and impact investor, including investments into early-stage biotechnology, life sciences, and health technology companies, but it does not itself run drug or device R&D.[3][6][8]

Industry: Investors

Partnerships

Brandon Capital Partners (investment relationship as a limited partner backing early-stage biomedical and life science ventures)[1][3]Various health technology and medtech startups as an institutional investor, including Heidi Health and OncoRes Medical via Brandon Capital-backed funds[1][3]Inventia Life Science (direct growth capital investment by HESTA as part of its health technology and innovation focus)[6][8]

Beyond the preview

Go deeper on HESTA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HESTA.

Explore the full profile